Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
about
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageChronic hepatitis C and liver fibrosis.Non-invasive prediction of forthcoming cirrhosis-related complications.Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis CNoninvasive tools to assess hepatic fibrosis: ready for prime time?A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic Biopsy.NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.Molecular and contextual markers of hepatitis C virus and drug abuse.FibroMAX: towards a new universal biomarker of liver disease?Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.What's new in dermatologic therapy.GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.HBV Viral Load and Liver Enzyme Levels May Be Associated with the Wild MBL2 AA Genotype.Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.Biomarkers of liver fibrosis.Invasive and non-invasive assessment of portal hypertension.Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.Non-invasive assessment of liver fibrosis.How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling.
P2860
Q26773289-5E4EC0D6-9D3D-4CCE-B121-DDC3B8C817A9Q26825671-22ECF01C-0099-4F02-96BC-994296FCD9CDQ27000645-703F9247-4FE9-46E6-A16C-C983C8786656Q30386788-0399569D-1DF2-4ADD-AFA5-CB961D80F4FDQ30464087-F8286C0B-330D-47B7-AA28-4652210A34F6Q30476922-B3C96C39-EF8D-4A9C-BD14-8F12A727459FQ34996766-1D40F48E-3AE4-42E0-BC8A-5401BE6133B5Q35225194-C62D24A9-43E7-433A-91C8-B505DCFE50AAQ35235447-876A2BA0-6C2B-4676-99B9-ECA4DD2941D6Q35660841-0013A825-3881-4C58-8311-63FC4AF1A225Q36950410-BE0A097C-33DE-47AA-ABC5-0C4990EDA4A6Q37002423-E830D6EB-98FC-4CF9-98EB-9DEC4F6A93DDQ37131029-1C47F901-22B0-4BD2-AEA1-A3B6DCB7C9CFQ37210696-A9C13AAC-471F-4B9B-89FC-6EEE22648933Q37734379-75E9AD6E-BCD9-4065-976D-36C0660651D5Q37801658-867F6F7A-5C60-48FB-8D06-80AE89A6D0A8Q37825547-2F1E4637-6AA8-4DAE-BEEB-EE523EE74E2EQ39210299-53792342-2BC1-4C85-901B-6ED44C02B6B8Q39840925-EA90B9EE-ED6C-435B-90C3-3201C37DE541Q40766803-B48862C9-4DAD-400B-AFBF-BED13BCD6298Q41356673-0123F881-B29C-4AC1-9E0F-09B6EB007BAFQ42406716-CEDC2E78-C595-4A64-B6BE-790866678A3AQ43046834-828B5FE5-90DB-4831-BDB4-BECA23129FF2Q44131260-D9796081-14D8-453F-9749-0B6D0CE78121
P2860
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
@en
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
@nl
type
label
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
@en
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
@nl
prefLabel
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
@en
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
@nl
P2093
P1476
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
@en
P2093
Atif Zaman
Christopher L Corless
Hugo R Rosen
Katie Smith
Ken Ingram
P304
P356
10.1016/J.AMJMED.2006.06.044
P407
P577
2007-03-01T00:00:00Z